Durable complete response to immunotherapy with anti-PD-1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report

Katsuhisa Sekido; Shuichi Imaue; Kei Tomihara; Hidetake Tachinami; Kentaro Yamagishi; Seisuke Okazawa; Atsushi Ikeda; Kumiko Fujiwara; Makoto Noguchi

doi:10.1002/ccr3.4545

Durable complete response to immunotherapy with anti-PD-1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report

Katsuhisa Sekido
, Shuichi Imaue^*
, Kei Tomihara
, Hidetake Tachinami
, Kentaro Yamagishi
, Seisuke Okazawa
, Atsushi Ikeda
, Kumiko Fujiwara
, Makoto Noguchi

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Although the optimal treatment method for metastatic oral cancer remains largely unknown, the present case suggests that immunotherapy is a potentially promising alternative for metastatic oral cancer in which other therapies are no longer effective.

Original language	English
Article number	e04545
Journal	Clinical Case Reports
Volume	9
Issue number	9
DOIs	https://doi.org/10.1002/ccr3.4545
State	Published - 2021/09

Keywords

anti-PD-1
complete remission
immune checkpoint inhibitor
lung metastasis
nivolumab
oral squamous cell carcinoma

ASJC Scopus subject areas

General Medicine

Access to Document

10.1002/ccr3.4545

Cite this

Sekido, K., Imaue, S., Tomihara, K., Tachinami, H., Yamagishi, K., Okazawa, S., Ikeda, A., Fujiwara, K., & Noguchi, M. (2021). Durable complete response to immunotherapy with anti-PD-1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report. Clinical Case Reports, 9(9), Article e04545. https://doi.org/10.1002/ccr3.4545

@article{417b85edac9e4b529fbebd27e5894f4d,

title = "Durable complete response to immunotherapy with anti-PD-1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report",

abstract = "Although the optimal treatment method for metastatic oral cancer remains largely unknown, the present case suggests that immunotherapy is a potentially promising alternative for metastatic oral cancer in which other therapies are no longer effective.",

keywords = "anti-PD-1, complete remission, immune checkpoint inhibitor, lung metastasis, nivolumab, oral squamous cell carcinoma",

author = "Katsuhisa Sekido and Shuichi Imaue and Kei Tomihara and Hidetake Tachinami and Kentaro Yamagishi and Seisuke Okazawa and Atsushi Ikeda and Kumiko Fujiwara and Makoto Noguchi",

note = "Publisher Copyright: {\textcopyright} 2021 The Authors. Clinical Case Reports published by John Wiley \& Sons Ltd.",

year = "2021",

month = sep,

doi = "10.1002/ccr3.4545",

language = "英語",

volume = "9",

journal = "Clinical Case Reports",

issn = "2050-0904",

publisher = "John Wiley and Sons Ltd",

number = "9",

}

TY - JOUR

T1 - Durable complete response to immunotherapy with anti-PD-1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis

T2 - A case report

AU - Sekido, Katsuhisa

AU - Imaue, Shuichi

AU - Tomihara, Kei

AU - Tachinami, Hidetake

AU - Yamagishi, Kentaro

AU - Okazawa, Seisuke

AU - Ikeda, Atsushi

AU - Fujiwara, Kumiko

AU - Noguchi, Makoto

PY - 2021/9

Y1 - 2021/9

N2 - Although the optimal treatment method for metastatic oral cancer remains largely unknown, the present case suggests that immunotherapy is a potentially promising alternative for metastatic oral cancer in which other therapies are no longer effective.

AB - Although the optimal treatment method for metastatic oral cancer remains largely unknown, the present case suggests that immunotherapy is a potentially promising alternative for metastatic oral cancer in which other therapies are no longer effective.

KW - anti-PD-1

KW - complete remission

KW - immune checkpoint inhibitor

KW - lung metastasis

KW - nivolumab

KW - oral squamous cell carcinoma

UR - https://www.scopus.com/pages/publications/85115675088

U2 - 10.1002/ccr3.4545

DO - 10.1002/ccr3.4545

M3 - 学術論文

C2 - 34484745

AN - SCOPUS:85115675088

SN - 2050-0904

VL - 9

JO - Clinical Case Reports

JF - Clinical Case Reports

IS - 9

M1 - e04545

ER -

Durable complete response to immunotherapy with anti-PD-1 antibody nivolumab in a patient with oral squamous cell carcinoma presenting with lung metastasis: A case report

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Fingerprint

Cite this